IC3: Pharmacology Flashcards

1
Q

What are the 4 phases of hemostasis?

A

Vasoconstriction
Primary hemostasis
Secondary hemostasis
Clot stabilisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What drugs should be used for the latter 3 stages of hemostasis?

A

Primary hemostasis - antiplatelets
Secondary hemostasis - anticoagulants
Clot stabilisation - fibrinolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 classes of antiplatelets and their respective drugs?

A

Adenosine uptake and PDE3i - dipyridamole
COX-1 inhibitor - aspirin
ADP P2Y12 inhibitors - clopidogrel, ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the MOA of dipyridamole

A

Dipyridamole inhibits adenosine reuptake, increasing plasma adenosine activation of A2 receptors on platelets, which then increases cAMP levels which inhibit platelet activation and aggregation

It also inhibits PDE3, hence reducing cAMP degradation in platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the main side effect of dipyridamole and why this occurs

A

Hypotension (dose-limiting SE) as dipyridamole acts as a vasodilator and inhibits adenosine reuptake and PDEs in vascular smooth muscle as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the MOA of aspirin

A

Aspirin is an irreversible cyclooxygenase (COX) inhibitor, inhibiting COX-1 more than COX-2 at lower doses

COX-1 (platelets) normally produces TXA2 which promotes platelet aggregation (effects for 7-10d)

COX-2 (endothelial cells) expresses PGI2 which inhibits platelet aggregation (effects for 3-4h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the main side effect for aspirin

A

Upper GI events (gastric ulcers, bleeding), as aspirin inhibits COX-1 production of protective PGs in the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is ADP P2Y12 important in platelet aggregation?

A

Platelets release ADP from their granules which act on the P2Y12 receptor, which plays an important role in activating GP IIb/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain how clopidogrel works

A

Clopidogrel is a prodrug whereby the active metabolite (metabolised by CYP2C19) irreversibly binds to the ADP binding site of P2Y12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain how ticagrelor works

A

Ticagrelor and its metabolites binds reversibly at an allosteric site of P2Y12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the main contraindications to clopidogrel and ticagrelor? (2 + 1 for ticagrelor)

A

Hypersensitivity
Pathological bleeding (eg. PUD)

Severe hepatic impairment for ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DDIs for clopidogrel (6)

A

warfarin
NSAIDs
salicylates
macrolides
PPI
CYP2C19 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DDIs for ticagrelor (6)

A

anticoagulants
fibrinolytics
long-term NSAIDs
aspirin (>100mg/day)
CYP3A4 inducers
CYP3A34 strong inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 3 classes of anticoagulants?

A

VKA - warfarin
DOACs - dabigatran (DTI, IIa), rivaroxaban (Xa)
Parenteral ACs - heparin, LMWH (enoxaparin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is vitamin K used in the coagulation pathway?

A

Active vitamin K is oxidised to inactive vitamin K to carboxylate glutamic acid residues on factors II, VII, IX and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is warfarin’s MOA

A

Warfarin inhibits vitamin K reductase that normally reactivates oxidised vitamin K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the 2 genetic polymorphisms implicated in warfarin use?

A

CYP2C19
VKORC1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the 3 main side effects of warfarin?

A

Bleeding
Hepatitis
Cutaneous necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DDIs with warfarin? (10)

A

Paracetanol
allopurinol
NSAIDs
salicylates
PPIs
metronidazole
barbituates
corticosteroids
spironolactone
thiazides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CI for warfarin (5)

A

hypersensitivity
active bleeding
HTN
renal or hepatic disease
pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is dabigatran etexilate’s MOA

A

Dabigatran etexilate is a prodrug that is rapidly converted to dabigatran, and dabigatran and its acyl glucuronide metabolites are competitive reversible non-peptide antagonists of thrombin (factor IIa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the adverse effects of dabigatran (2)

A

bleeding
GI symptoms (dyspepsia, abd discomfort)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the reversal agent for dabigatran and what is its MOA?

A

Idarucizumab, binds dabigatran and its acyl glucuronide metabolites with higher affinity than dabigatran binds to thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the MOA of rivaroxaban?

A

Rivaroxaban is a competitive reversible antagonist of activated factor Xa

25
Q

What is the reversal agent for rivaroxaban?

A

Andexanet alfa

26
Q

Explain the general MOA of parenteral anticoagulants (heparin, LWMH)

A

They potentiate the action of antithrombin III (causing conformational change)

The heparin-AT III complex inactivates coagulation factors IIa, IXa, Xa, XIa and XIIa (mainly IIa and Xa)

27
Q

Compare between LMWH enoxaparin and heparin (2)

A

Enoxaparin is more selective for factor Xa (less for factor IIa)

Enoxaparin causes a lower instance of thrombocytopenia

28
Q

What are the main 2 side effects of heparin?

A

Bleeding
Heparin-induced thrombocytopenia

29
Q

What is the reversal agent for heparin and what is its MOA

A

Protamine sulfate IV infusion, stably binds to heparin and neutralises its anticoagulant property

30
Q

Explain how heparin-induced thrombocytopenia is caused

A

Heparin binds to platelet factor 4 (PF4) on activated platelet surface, causing the body to form IgG antibodies against the heparin-PF4 complex (lower risk of thrombocytopenia with LMWHs)

31
Q

DDIs with heparin/LMWH (5)

A

Antiplatelets
Anticoagulants
Fibrinolytics
NSAIDs
SSRIs

32
Q

Explain how endogenous thrombolysis occurs and how it stops

A

Tissue-type plasminogen activator binds to plasminogen and converts it to plasmin

tPA is inactivated when it binds to plasminogen activator inhibitor-1 and subsequently destroyed in the liver

33
Q

What are the benefits of using alteplase over urokinase and streptokinase

A

they bind preferentially to clot-associated plasminogen, activating plasmin at the clot itself

34
Q

When are fibrinolytics indicated?

A

Fibrinolytics are only used to treat existing clots causing iminent risk of irreversible damage or death (eg. thrombotic stroke or pulmonary embolism)

35
Q

What are the two reversal agents for fibrinolytics (rtPA)?

A

Tranexamic acid and aminocarpoic acid, which compete for the lysine binding sites on plasminogen and plasmin, blocking their interaction with fibrin

36
Q

What are the contraindications for fibrinolytics (rtPA)? (4)

A

active bleeding
hemorrhage
surgery
stroke

37
Q

DDIs with fibrinolytics? (2)

A

antiplatelets (dipyridamole, aspirin)
anticoagulants (warfarin, heparin)

38
Q

What are the 4 main drug-induced blood dyscrasias?

A

Aplastic anemia
Immune thrombocytopenia
Agranulocytosis
Hemolytic anemia

39
Q

What are the causes of aplastic anemia (2 x 2)

A

Dose-dependent direct drug toxicity caused by cancer chemotherapies and chloramphenicol

Idiosyncratic (toxic metabolites) caused by carbamazepine and phenytoin

40
Q

5 management strategies for aplastic anemia

A

Withdraw the causative drug whenever possible

Immunosuppressants

Transfusion of erythrocytes and platelets may be done

Other drugs such as granulocyte-macrophage colony-stimulating factor (GM-CSF) sargramostim, and granulocyte CSF (G-CSF) filgrastim, and interleukin-14 may be given

Hematopoietic stem cell transplantation may be necessary

41
Q

5 drugs that can cause immune thrombocytopenia

A

heparin
sulfonamides
carbamazepine
phenytoin
GP IIb/IIIa inhibitors (eptifibatide)

42
Q

3 management strategies for thrombocytopenia

A
  • Withdraw the causative drug whenever possible
  • Immunosuppressants are used
  • Platelet transfusions can be given if there is clinically significant bleeding
43
Q

What are the 3 classes of agranulocytosis

A
  • Direct drug toxicity caused by thiamazole, chlorpromazine, ticlopidine, busulfan, zidovudine
  • Toxic metabolite caused by clozapine, carbimazole
  • Immune mediated (hapten or complement) caused by beta-lactam antibiotics, propylthiouracul
44
Q

3 management strategies for agranulocytosis

A
  • Withdraw the causative drug whenever possible
  • Prophylactic administration of hematopoietic growth factors such as GM-CSF sargramostim and G-CSF filgrastim may be done as well
  • Routine (weekly) monitoring of WBC count, particularly for patients treated with clozapine
45
Q

Main causes of immune (3) and non-immune (1) hemolytic anemia

A

Immune hemolytic anemia
- Drug induced true autoantibody production caused by methyldopa
- Innocent bystander (immune complex) autoantibody production caused by quinine and quinidine
- Hapten induced hemolysis caused by penicillins, cephalospirins, streptomycin

Non-immune hemolytic anemia
- Protein adsorption caused by cisplatin, oxaliplatin and beta-lactamase inhibitors

46
Q

5 management strategies for hemolytic anemia

A
  • Withdraw the causative drug whenever possible
  • RBC transfusion for pts with very low hemoglobin
  • Hemodialysis may be required for those in acute renal failure
  • Steroids and immunoglobulins have been used in serious cases
  • For autoimmune hemolytic anemia, rituximab (human anti-CD20 monoclonal antibody) can be used
47
Q

What should you give for iron-deficient anemia?

A

Iron can be given orally (ferrous sulfate) or parenterally (iron sucrose)

48
Q

What is the main adverse effect with giving iron for IDA?

A

Hemochromatosis

49
Q

What reversal agents can be given for iron overdose?

A

Deferoxamine (parenteral)
Deferasirox (oral)

50
Q

What should you give for vitamin B12 deficiency?

A

hydroxocobalamin

51
Q

What is contraindicated for folic acid deficiency?

A

untreated B12 deficiency (treat B12 first)

52
Q

What are the adverse effects of treating with folic acid? (2)

A

Bitter/bad taste
Nausea

53
Q

What are the DDIs with folic acid? (5)

A

Anticonvulsants, lithium, MTX, aspirin, bactrim

54
Q

What are the 3 ESAs that can be given in anemia?

A

dabepoetin alfa
epoetin alfa
methoxy PEG-epoetin beta

55
Q

What are the main adverse effects of ESAs? (2)

A

hypertension
thrombosis

56
Q

What drugs can be given for neutropenia? (2)

A

G-CSF filgrastim with HSC mobiliser plerixafor

GM-CSF sargramostim

57
Q

What is the prominent adverse effect for G-CSF (filgrastim)?

58
Q

What are the three drugs that can be given for thrombocytopenia

A

Oprelvekin (recombinant IL-11)
Romiplostim (thrombopoietin agonist)
Eltrombopag (thrombopoietin agonist)

59
Q

What is the main adverse event for thrombocytopenia drugs?

A

thromboembolic events